Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Regorafenib EP impurity A
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Yes -Refer MSDS for accurate information
AFP-Picolin Methylamide Impurity is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
AFP-Picolin Methylamide Impurity usage and description
AFP-Picolin Methylamide Impurity is a chemical compound used in the pharmaceutical industry as a reference standard in analytical testing. It is also used in the development and validation of analytical methods for quality control of pharmaceuticals. The compound is a known impurity of AFP-Picolin, which is a potential drug candidate for the treatment of cancer.
Chemically, AFP-Picolin Methylamide Impurity is a derivative of AFP-Picolin, which is a type of pyridine-based molecule. The compound is characterized by the presence of a methylamide group, which is attached to the pyridine ring. The impurity is formed during the synthesis of AFP-Picolin and can significantly affect the purity and quality of the final drug product.
Analytical methods such as High-Performance Liquid Chromatography (HPLC) and Gas Chromatography-Mass Spectrometry (GC-MS) are used to detect and quantify AFP-Picolin Methylamide Impurity in pharmaceutical samples. The impurity is considered harmful to human health and must be controlled within acceptable limits during drug development and manufacturing.
In conclusion, AFP-Picolin Methylamide Impurity is a critical compound in the pharmaceutical industry, used for analytical testing and quality control of potential cancer drugs. Its chemical properties and analytical methods used for its detection and quantification are essential for ensuring the safety and efficacy of pharmaceutical products.
